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ABSTRACT
Objective: To investigate prevalence, persistence and clinical correlates of increased microalbu-
min excretion in random urine samples collected in a paediatric diabetes clinic. 
Method: Random urine samples were collected annually in patients >10 years attending the dia-
betes clinic in the Royal Hospital for Sick Children, Edinburgh. Albumin excretion is expressed as
albumin:creatinine ratio (ACR) and classified as normal (<3.5 mg/mmol), equivocal (3.5-10
mg/mmol), microalbuminuria (>10mg/mmol), or macroalbuminuria (>47 mg/mmol in females,
>35 mg/mmol in males). We analyzed retrospectively results on 421 urine samples collected from
217 patients (109 males), of a median age of 12.3 years (94% 10-16 years) over 3 years. For
each sample, the corresponding mean HbA1c over the previous year was calculated. 
Results: Prevalence of micro- and macro-albuminuria in individual samples was 1% and 0.5%
respectively. ACR was equivocal in 10.1% and 4.7% in samples from females and males respec-
tively (p=0.03). HbA1c showed borderline significant differences across ACR groups (p=0.06).
Equivocal ACR excretion was associated with slightly higher mean HbA1c (9.5±1.3%) compared
to normal albuminuria (9.0±1.1%, p<0.05). Multiple regression modelling indicated that increas-
ing age (p=0.02), female sex (p=0.05) but not HbA1c (p=0.79) were associated with a greater
likelihood of ACR >3.5 mg/mmol. The 14-16 years age group patients were most likely to have
ACR >3.5 mg/mmol (p=0.05).
Conclusions: Female sex and increasing age, but not HbA1c, were independently associated
with increased ACR. A robust mechanism for collection of repeat early morning urine samples
from patients with increased ACR in random urine samples, and follow-up of those patients who
have persistently high microalbumin excretion are important. It is also important  to confirm the
usefulness of ACR measurements in random urine samples as a marker of incipent nephropathy.
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INTRODUCTION
Age, sex, duration of the diabetes,
glycemic control, blood pressure and genet-
ic susceptibility are considered as risk factors
which influence the development of early
nephropathy in childhood type 1 dia-
betes.(1) Early detection of a rise in albumin
excretion while still within the normal range
would enable  intervention to prevent the
development of incipient nephropathy.(2, 3,
4) Therefore, annual screening of albumin
excretion in urine for early detection of
microalbuminuria (MA) is both necessary
and useful, especially in children with dia-
betes of a duration greater than 10 years.
This screening requires careful collection of
the urine sample.  Accurately timed urine is
necessary to determine albumin excretion
rate (AER) and this is considered as the gold
standard in urine collection. However, when
this is not possible, determination of albu-
min/creatinine ratio (ACR) in early morning
urine (EMU) or in random urine specimens
are other alternatives which can be used for
detection of MA.(5)
There is an unequivocal relationship
between poor glycemic control and the
development of MA.(6) However, inde-
pendent of poor glycemic control, early
diabetic complication risk increases with
the onset of puberty. In addition, compared
with male patients, MA risk is twofold
greater in pubertal female patients.(1, 7)
This is in contrast to lifetime risk of diabet-
ic nephropathy, which is greater in male
patients.(8) Diabetes Control and
Complication Trial (DCCT) data showed
that despite intensive insulin therapy,  MA
and elevated HbA1c prevalence was higher
in adolescents than in adults.(9)
This study  was designed to investigate
the prevalence and persistence of
increased microalbumin excretion in ran-
dom urine samples collected in a paedi-
atric diabetes clinic. We also analysed MA
risk based on  clinical correlates such as
age, sex and HbA1c.
SUBJECTS AND METHODS
All patients attending the diabetes
clinic in the Royal Hospital for Sick
Children (RHSC), Edinburgh for 3 years
were evaluated retrospectively for MA.
MA was measured in terms of ACR in ran-
dom urine samples annually in all
patients. Albumin was measured by tur-
bidimetry on the Olympus analyser.
Creatinine was measured by the Jaffe
method. HbA1c was measured by an
immunological method on the DCA 2000
analyser, at least four times a year and
mean HbA1c for the previous year was
calculated for each patient from these
measurements. MA results in 23 urine
samples did not match HbA1c results and
were excluded. In addition, unnecessary
repeat urine samples (n=12) and dilute
urine samples (n=7) were also excluded.
A urine sample was considered too dilute
if the creatinine was so low that it was not
possible to determine whether the albu-
min excretion was normal or abnormal.
The final number of urine samples for MA
measurements included in the study was
a total of 421, with corresponding  HbA1c
measurements, from 217 diabetic patients.
108 of these patients were females
(49.8%) and 109 (50.2%) were males. Age
and sex information for each patient was
obtained from the hospital database.
There were only few samples from
patients younger than 10 years and older
than 16 years. The age distribution was
similar for males and females (Figure 1).
Microalbumin was measured in terms of
ACR in random urine samples and catego-
rized as follows:(10)
• <3.5 mg/mmol Þ Normoalbuminuria
• 3.5-10 mg/mmol Þ Equivocal
• >10 mg/mmol Þ MA
• >47 mg/mmol Þ Macroalbuminuria 
If ACR showed normoalbuminuria, no
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next annual follow-up. If ACR exceeded
normoalbuminuria or if the urine was so
dilute that it was not possible to evaluate
microalbumin excretion, a repeat sample
was collected at the next clinic visit. If this
repeat sample also showed equivocal or
increased microalbumin excretion, the
patient was instructed to collect an EMU. If
the EMU showed normoalbuminuria, it was
assumed that any previous equivocal or
increased microalbumin excretion was due
to orthostatic/exercise effects. Patients with
equivocal or increased microalbumin
excretion did not receive specific treatment
other than advice regarding diabetes con-
trol and continued to be monitored at
annual intervals.
MA data included many samples for
which microalbumin was <5 mg/L with vary-
ing creatinine concentrations, resulting in
normal (<3.5 mg/mmol) but not precisely
quantifiable microalbumin normalised to
creatinine. For statistical analysis, a result of,
for example, <3.5 mg/mmol was expressed
as 3.1 mg/mmol.
Patients were grouped by MA cate-
gories and by age. By microalbumin cate-
gories, group I designates normoalbumin-
uria, group II patients with equivocal
results, and group III MA and macroalbu-
minuria. Age categories included five
groups: <10, 10-12, 12-14, 14-16, and >16
years (figure 1). 
Statistical Analysis
We used both SPSS and Eviews for statis-
tical analysis. Summary statistics are given as
mean ± SD and/or median. Comparison of
boys versus girls were based on two-sample
t-test statistics. Pairwise equality of the
means as well as equality of group means
collectively were compared using Wald test
based on c2-statistic to overcome small sam-
ple bias for some groups.
To test the effects of age, sex and mean
HbA1c on the MA risk level, multiple
regression analysis was used. Furthermore,
controlling for the effects of sex and
HbA1c, another multiple regression was
run to detect which age group was at a
higher risk level. All p-values in both
regressions were calculated according to
c2-statistic. Dummy variable multiple
regression method was used allowing to
test the pairwise or collective equality of
estimated regression coefficients which
show that mean value of each variable
under consideration across specific cate-
gories such as age and sex.
RESULTS
Sample-based average age was 12.4 ± 1.2
(median 12.3 with a range of 1.1-22.2) years.
Both the sample-based and patient-based
distributions across sex were equal (female
patients and samples: 49.8% and 49.2%,
male patients and samples: 50.2% and
50.8%).
Mean HbA1c was 9.07 ± 1.1% (median
9, range 6.3-12.8) and MA value 2.39 ±
9.15 mg/mmol (median 1.1, range 0.1-
175.4) in the whole sample. HbA1c mean
for females was 9.1 ± 1.1% and for males
9.0 ± 1.0%. Median HbA1c value was 9%
for both females and males. Mean MA
value of females (3.1 ± 12.8 mg/mmol)
was not statistically different (p=0.13)
from mean MA of males (1.7 ± 2.3
Figure 1: Sample based age distribution
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12-14 14-16 >16mg/mmol). Median MA was 1.2 mg/mmol
and 1 mg/mmol for males and females,
respectively.
The prevalence of MA was found to be
1% while prevalence was 0.5% for macroal-
buminuria.  In 7.4% of the samples (10.1% of
samples from females and 4.7% of those from
males, p=0.03) ACR results were equivocal
(Figure 2). 
Using Wald test based on c2-statistic, it
was also tested whether there is any differ-
ence with respect to sex within each
microalbumin category. There was a statis-
tically significant difference regarding sex
in group I (males > females; p=0.04) and
group II (males < females; p=0.03, i.e., pro-
portionately more females than males had
equivocal albumin excretion) and no signif-
icant difference between females and males
in group III.
There were 37 non-normal samples
(8.8%) of which 31 were equivocal, 4 MA,
and 2 macroalbuminuria from a total of 74
samples from 32 patients (21 females, 11
males).  The clinical and biochemical fea-
tures of patients with micro-and-macroalbu-
minuria are shown in Table 1. 
There were 25 patients for whom fol-
low-up samples were available. Six patients
either remained in the same category or
showed inconsistent fluctuations. 8 of 10
patients who improved were females.
Spontaneous regression and progression
rates were 40% and 36%, respectively.
There was no overall significant differ-
ence among microalbumin groups with
respect to age (p=0.13). HbA1c showed bor-
derline significant differences across ACR
groups (p=0.06). 
Equivocal ACR excretion was associat-
ed with slightly higher HbA1c (9.5±1.3%)
Table 1: Clinical and biochemical features of patients with micro and macroalbuminuria
Chronological age ACR Mean HbA1c
Sex (decimal years) MA category (mg/mmol) (%)
F 12.4 H 175.4 9.98
F 14.3 H 50.5 7.90
M 11.0 M 12.9 8.37
M 12.1 M 13.5 9.00
F 13.1 M 36.7 9.10
M 14.2 M 21.9 9.50
H: Macroalbuminuria category, M: Microalbuminuria category
Table 2: Comparison of age and HbA1c across microalbuminuria groups
Group I Group II Group III Overall Difference Pair-wise Difference
Age Groups I & II
(mean ± SD) 12.4 ± 2.0 13.1 ± 1.3 12.9 ± 1.8 p=0.13 p<0.05
Range 1.1-22.2 10.2-20.2 11.0-14.3
HbA1c Groups I & II
(mean ± SD) 9.04 ± 1.07 9.51 ± 1.29 8.98 ± 0.75 p=0.06 p<0.02
Range 6.30-12.80 6.67-12.70 7.90-9.98
Table 3: The association of MA risk with age, sex and HbA1c
Variable Coefficient p
Constant 1.09 0.00
Age 0.05 0.02
Sex 0.07 0.05
HbA1c -0.01 0.79
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than normal excretion (9.0±1.1%, p<0.05)
(Table 2).
Multiple regression modelling indicated
that increasing age (p=0.02), female sex
(p=0.05) but not HbA1c (p=0.79) were
associated with a greater likelihood of ACR
>3.5 mg/mmol in random urine samples.
The 14-16 year age group were most likely
to have ACR >3.5 mg/mmol (p=0.05)
(Table 3).
DISCUSSION
Diabetic nephropathy is a leading cause
of increased morbidity and mortality in
patients with type 1 diabetes. MA is an early
predictor for diabetic nephropathy and is
rarely detected before puberty. Its preva-
lence in adolescence varies from 4% to 20%,
depending on the patient population and
the screening method.(11, 12, 13) Annual
ACR control in random urine is useful as a
screening for the early detection of  MA.(10,
14) If and when necessary, EMU can be
requested as a second step. It is suggested
that multiple samples should be taken to
minimise biological variation. As a rule of
thumb, ACR is above the cut-off value in two
thirds of total EMU samples.(5)
According to our results, the prevalence
of elevated ACR was 9% in our group of dia-
betic children. In the Danish study, this ratio
was 13%. The youngest patient with MA was
15.3 years old in the Danish study whereas
11 years old in our study. While the oldest
patient with macroalbuminuria was 19.1
years old in Danish study, it was 14.2 in our
study. The onset of MA and macroalbumin-
uria was earlier in our study. Mean HbA1c in
the Danish cohort study was 9.7% and only
a few patients had values below 8%.(12) Our
mean HbA1c was 9% with no significant dif-
ference between females and males. Fifteen
percent  of the HbA1c samples showed val-
ues  below 8%.
Both sample-based and patient-based
distributions of females and males in all
microalbumin groups were very similar.
However, equivocal samples from female
patients were twice higher than males.
Overall, females had higher MA values in
micro-and-macroalbuminuric groups. Con-
sistent with previous literature,(7, 15, 16)our
results also indicate that especially adoles-
cent females with diabetes are at a higher
MA risk compared to males.
MA risk increases also with age.(1) The
Danish study showed an increasing preva-
lence with age, reaching 14% by 17-18
years.(17) Patients with equivocal ACR-
results should be followed up closely con-
sidering that they are within the grey
zone, especially starting with the onset of
puberty. 
It is well known that poor glycemic con-
trol leads to an increase in diabetic compli-
cations. In our study, it was surprisingly
found that glycemic control did not appear
to influence MA risk. In the Danish experi-
ence, MA prevalence was related to HbA1c
only in girls.(17) In other studies, it is
reported that MA is unequivocally related to
poor glycemic control, but that the increas-
ing prevalence of MA during puberty cannot
be entirely explained by HbA1c.(7) These
Figure 2: Gender differences across the MA groups
Group 1: Normoalbuminuria; Group II: Equivocal result; Group III: Micro
and macroalbuminuriafindings  raise a question on the possibility
of potential factors for MA risk other than
HbA1c, especially in females in the pubertal
period. Transient insulin resistance during
puberty may have a role to development of
MA. Amin et al(7) pointed out the link
between hormonal changes (hyperandro-
genism, low-sex hormone binding globulin
[SHBG], insulin like growth factor [IGF1]
levels) and MA in female adolescent
patients. Hormonal changes during puberty
may effect the development of MA especial-
ly in susceptible girls. The development of
MA at puberty may reflect not only poor
glycemic control but also changes in the
growth hormone-IGF1 axis and ovarian
function.(7)
DCCT data, on the other hand, demon-
strate that hyperglycaemia plays a prominent
role in development of microvascular com-
plications in adolescents. Aggressive insulin
therapy has been shown to reduce diabetic
complication risk.(6) However, this may
confer increased weight gain and hypogly-
caemia and predispose the paient to the
detrimental effects of peripheral hyperinsu-
linemia, such as the development of ovarian
hyperandrogenism.(7) We also know that
puberty is characterised by relative insulin
resistance,(18) and near-normoglycaemia
may be difficult to achieve in this period.
12
Insulin resistance can predate the appear-
ance of MA.(19) Ovarian hyperandrogenism
in polycystic ovarian syndrome is related to
insulin resistance and peripheral hyperinsu-
linemia.(20) The GH-associated increase in
insulin resistance during puberty in type 1
diabetes may be the principal cause of the
ovarian hyperandrogenism.(7)
However, the relationship between MA
and blood pressure is still controversial. It
has been  claimed that blood pressure is not
an important initiating factor for MA in chil-
dren with type 1 diabetes.(14, 21)
In conclusion, female sex and increasing
age, but not HbA1c, were independently
associated with increased ACR in random
urine samples from adolescents. Orthostatic
and other factors unrelated to glycemic con-
trol may have contributed to these findings. 
Patients with equivocal ACR-results should
be followed up closely, especially after the
onset of puberty. Given that there was no sig-
nificant relation between MA risk and HbA1c
in our study, further research is needed to
completely clarify this relationship, especially
in females in the pubertal period.
A robust mechanism for collection of
repeat early morning urine samples from
patients with increased ACR in random urine
samples, and follow-up of those patients
who have persistently high microalbumin
excretion are important in the care of diabet-
ic patients. It is also important  to further
confirm the usefulness of ACR measure-
ments in random urine samples as a marker
of incipent nephropathy.
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